导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.60% | 568/1050 |
| 近一周 | -2.55% | 653/1104 |
| 近一月 | -9.65% | 1022/1102 |
| 近一季 | 14.40% | 61/1092 |
| 近半年 | 2.90% | 359/1070 |
| 近一年 | -17.59% | 850/1018 |
| 近两年 | 6.89% | 856/926 |
| 近三年 | -21.13% | 780/834 |
| 成立以来 | 143.11% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.80% 628/1070 |
1.43% 673/1101 |
- - |
- - |
| 2025 | -1.48% 940/1065 |
5.03% 413/1014 |
0.56% 646/1038 |
11.86% 812/1050 |
-16.61% 1001/1065 |
| 2024 | -19.52% 900/1011 |
-13.89% 885/960 |
-9.68% 853/983 |
17.24% 127/991 |
-11.75% 946/1011 |
| 2023 | -14.11% 486/952 |
-3.14% 751/880 |
-7.53% 668/895 |
-3.50% 229/915 |
-0.63% 146/952 |
| 2022 | -21.26% 380/867 |
-17.23% 374/773 |
4.22% 568/806 |
-14.19% 519/845 |
6.38% 154/867 |
| 2021 | -6.91% 447/740 |
-1.14% 196/580 |
18.62% 177/659 |
-10.27% 517/704 |
-11.54% 669/740 |
| 2020 | 59.13% 201/554 |
2.07% 112/419 |
35.28% 71/466 |
3.08% 387/517 |
11.81% 301/554 |
| 2019 | 56.99% 96/410 |
35.58% 128/1149 |
-0.18% 369/1231 |
10.73% 101/390 |
4.75% 345/410 |
| 2018 | -9.09% 6/349 |
- - |
- - |
- - |
-13.39% 782/1080 |
| 2017 | 32.67% 31/285 |
- - |
- - |
- - |
- - |
| 2016 | -17.12% 101/205 |
- - |
- - |
- - |
- - |
| 2015 | 42.68% 35/151 |
- - |
- - |
- - |
- - |
| 2014 | 40.94% 2/24 |
- - |
- - |
- - |
- - |
| 2013 | 12.05% 12/21 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 中海医疗保健主题股票A VS. 东吴新产业精选股票A(580008) |